Cassava Sciences Inc (SAVA) Live Share Price, Invest From India

Cassava Sciences Inc Stock Performance

as on March 11, 2026 at 6:59 am IST

Day's Low
Day's High
$2.19
Day's Price Range
$2.49
$2.38
7.98%
Downside
4.62%
Upside
52 Week's Low
52 Week's High
$1.15
52-Week Price Range
$4.98
$2.38
51.68%
Downside
109.24%
Upside

Cassava Sciences Inc share price movements today

Previous Close: $2.12
Open: $2.19
Volume: 2.5M
Day's Low - High: $2.19 - $2.49
52 Week Low - High: $1.15 - $4.98

Cassava Sciences Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Cassava Sciences Inc Stock Fundamentals & Key Indicators

Check Cassava Sciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Cassava Sciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cassava Sciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cassava Sciences Inc	BUY	$-	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$41.9B	133.32%	135.08	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$112.6B	109.6%	28.91	32.94%
Beone Medicines Ltd	NA	$32.6B	NA	115.01	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$79.2B	62.69%	18.05	31.41%

Analyst Recommendation on Cassava Sciences Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Cassava Sciences Inc. Average target price of $8

Cassava Sciences Inc Share Price Target

Get share price movements and forecasts by analysts on Cassava Sciences Inc.

What analysts predicted

70.25%UPSIDE

Target Price

Current Price

$2.38

Analyzed by

8 Analysts

Target

$8.00

Cassava Sciences Inc target price $8, a slight upside of 70.25% compared to current price of $2.38. According to 8 analysts rating.

Cassava Sciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	2	-	-	-	1	-	-	0
Gross Profit	0	-23	-18	-16	-15	-17	-20	-13	-5	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-26	-25	-20	25	6	-27	-27	-23	-44	-10
Net Profit Margin	0.00%	0.00%	-890.93%	0.00%	0.00%	0.00%	-2258.35%	0.00%	0.00%	-1286.55%

Cassava Sciences Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	0	-	-
Gross Profit	-9	-9	-7	-2	-1	-3	0	0	-89	-1
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-14	-14	-11	-6	-4	-6	-31	-72	-97	-24
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	4026222.22%	0.00%	0.00%

Global Institutional Holdings in Cassava Sciences Inc

Funds	Holdings
D. E. Shaw & Co LP	0.97%
GMT Capital Corp	0.93%
State Street Corp	0.44%
UBS Group AG	0.39%
683 Capital Management LLC	0.88%

See all

Insights on Cassava Sciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 53.3%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 77.2% return, outperforming this stock by 168.7%
NEGATIVE IMPACT
Price Dip
In the last 3 years, SAVA stock has moved down by -91.5%

About Cassava Sciences Inc

Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, investigational treatments for central nervous system disorders, including Alzheimer’s disease and tuberous sclerosis complex (TSC)-related seizures. The Company's science is based on stabilizing, but not removing, a critical protein in the brain for patients with disorders such as Alzheimer’s disease or TSC. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease and TSC-related epilepsy. Simufilam targets an altered form of a protein called filamin A (FLNA) in the brain of patients with disorders such as Alzheimer’s disease or TSC. SavaDx, its lead investigational diagnostic product candidate, early-stage program focused on detecting the presence of Alzheimer’s disease from a small sample of blood.

Organisation	Cassava Sciences Inc
E-voting on shares	Click here to vote

FAQs

What is Cassava Sciences Inc share price today?

Cassava Sciences Inc share price today is $2.38 as on March 11, 2026 at 1:29 am IST. Cassava Sciences Inc share today touched a day high of $2.49 and a low of $2.19.

What is the 52 week high and 52 week low for Cassava Sciences Inc share?

Cassava Sciences Inc share touched a 52 week high of $4.98 on October 16, 2025 and a 52 week low of $1.15 on April 10, 2025. Cassava Sciences Inc stock price today i.e. March 11, 2026 at 1:29 am IST is trending at $2.38,which is 52.21% down from its 52 week high and 106.96% up from its 52 week low.

How to invest in Cassava Sciences Inc Stock (SAVA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cassava Sciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cassava Sciences Inc Shares that will get you 0.6303 shares as per Cassava Sciences Inc share price of $2.38 per share as on March 11, 2026 at 1:29 am IST.

What is the minimum amount required to buy Cassava Sciences Inc Stock (SAVA) from India?

Indian investors can start investing in Cassava Sciences Inc (SAVA) shares with as little as ₹93.295 or $1 (as of April 1, 2026 at 10:51 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹932.95 in Cassava Sciences Inc stock (as per the Rupee-Dollar exchange rate as on April 1, 2026 at 10:51 pm IST). Based on Cassava Sciences Inc share’s latest price of $2.38 as on March 11, 2026 at 1:29 am IST, you will get 4.2017 shares of Cassava Sciences Inc. Learn more about fractional shares .